In a recent dvm360® interview, Kirsten Oliver, VN, DipAVN (Surgical), CVT, CCRP, CVPP, VTS (Physical Rehabilitation), detailed the advantages of a suite of new products designed to improve pain management in animals.
In a dvm360® interview at the recent Atlantic Coast Veterinary Conference(ACVC), Kirsten Oliver, VN, DipAVN (Surgical), CVT, CCRP, CVPP, VTS (Physical Rehabilitation), highlighted the benefits surrounding the latest products to enter the pain management space within veterinary medicine.
View the video below for the entire discussion. The following is a partial transcript:
Kirsten Oliver, VN, DipAVN (Surgical), CVT, CCRP, CVPP, VTS (Physical Rehabilitation): There are a lot of pharmaceutical companies coming out with new and exciting drugs as they tailor down and understand more about the pain pathway, and how these drugs can actually interact with that and help improve pain management in animals with fewer side effects.
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Torsemide for canine CHF: Emerging evidence and clinical benefits
June 5th 2025William Rausch, DVM, DACVIM (Cardiology), explains that torsemide offers at least equivalent efficacy to furosemide in canine CHF while significantly reducing short-term mortality/worsening events by approximately 50%.
Read More